Literature DB >> 7847351

Karyomegalic interstitial nephritis: further support for a distinct entity and evidence for a genetic defect.

M Spoendlin1, H Moch, F Brunner, W Brunner, H R Burger, D Kiss, W Wegmann, P Dalquen, M Oberholzer, G Thiel.   

Abstract

Karyomegalic interstitial nephritis was first described in 1979 by Mihatsch, who was reporting three such cases. We report here four additional cases as well as two family investigations. Our findings support the association of karyomegaly and interstitial nephritis as a distinct entity. Typical clinical features are asymptomatic progressive renal failure in the third decade of life and recurrent infections, mostly of the upper respiratory tract. Histologic alterations consist of markedly enlarged and hyperchromic nuclei in many tubular epithelial cells throughout the nephron accompanied by interstitial fibrosis in the surrounding atrophic tubules. Karyomegaly is not limited to the kidneys. In one case, autopsy revealed karyomegaly in epithelial and mesenchymal cells of many other organs. However, no association of karyomegaly with further histologic damage is evident except in the kidneys. Because of the familial clustering, karyomegalic interstitial nephritis seems to be an inherited disease. Examination of the nuclear proliferation-associated structures proliferating cell nuclear antigen/cyclin, Ki 67, and p53 suggests an inhibition of mitosis in karyomegalic cells. The finding of the same HLA haplotype, A9/B35, in four of six HLA-typed cases suggests the possibility of a genetic defect on chromosome 6, which is inherited and linked to the HLA locus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7847351     DOI: 10.1016/0272-6386(95)90005-5

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  13 in total

1.  Karyomegalic interstitial nephritis.

Authors:  N Bennani Guebessi; M Karkouri
Journal:  CEN Case Rep       Date:  2015-11-24

2.  Improvement in karyomegalic interstitial nephritis three years after ifosfamide and cisplatin therapy by corticosteroid.

Authors:  Tomokazu Matsuura; Shu Wakino; Ayumi Yoshifuji; Toshifumi Nakamura; Hirobumi Tokuyama; Akinori Hashiguchi; Konosuke Konishi; Takeshi Iwasa; Masaaki Shoji; Ako Hosono; Ken Ohashi; Hirokazu Chuman; Hiroshi Itoh
Journal:  CEN Case Rep       Date:  2014-06-04

3.  [Eulogy to Prof. Dr. Med. Michael J. Mihatsch : Presentation of the Rudolf Virchow Medal 2019 of the German Society of Pathology].

Authors:  H Moch
Journal:  Pathologe       Date:  2019-12       Impact factor: 1.011

Review 4.  Diseases associated with defective responses to DNA damage.

Authors:  Mark O'Driscoll
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-12-01       Impact factor: 10.005

5.  A FANCD2/FANCI-Associated Nuclease 1-Knockout Model Develops Karyomegalic Interstitial Nephritis.

Authors:  Rannar Airik; Markus Schueler; Merlin Airik; Jang Cho; Jonathan D Porath; Elina Mukherjee; Sunder Sims-Lucas; Friedhelm Hildebrandt
Journal:  J Am Soc Nephrol       Date:  2016-03-29       Impact factor: 10.121

6.  Karyomegalic interstitial nephritis with focal segmental glomerulosclerosis: A rare association.

Authors:  S Radha; A Tameem; B S Rao
Journal:  Indian J Nephrol       Date:  2014-03

7.  Karyomegalic-like nephropathy, Ewing's sarcoma and ifosfamide therapy.

Authors:  Tom McCulloch; Andrew Prayle; Andy Lunn; Alan R Watson
Journal:  Pediatr Nephrol       Date:  2011-03-18       Impact factor: 3.714

8.  FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair.

Authors:  Weibin Zhou; Edgar A Otto; Andrew Cluckey; Rannar Airik; Toby W Hurd; Moumita Chaki; Katrina Diaz; Francis P Lach; Geoffrey R Bennett; Heon Yung Gee; Amiya K Ghosh; Sivakumar Natarajan; Supawat Thongthip; Uma Veturi; Susan J Allen; Sabine Janssen; Gokul Ramaswami; Joanne Dixon; Felix Burkhalter; Martin Spoendlin; Holger Moch; Michael J Mihatsch; Jerome Verine; Richard Reade; Hany Soliman; Michel Godin; Denes Kiss; Guido Monga; Gianna Mazzucco; Kerstin Amann; Ferruh Artunc; Ronald C Newland; Thorsten Wiech; Stefan Zschiedrich; Tobias B Huber; Andreas Friedl; Gisela G Slaats; Jaap A Joles; Roel Goldschmeding; Joseph Washburn; Rachel H Giles; Shawn Levy; Agata Smogorzewska; Friedhelm Hildebrandt
Journal:  Nat Genet       Date:  2012-07-08       Impact factor: 38.330

9.  How much should we involve genetic and environmental factors in the risk assessment of mycotoxins in humans?

Authors:  Edmond E Creppy; Serge Moukha; Hassen Bacha; Maria Rosaria Carratu
Journal:  Int J Environ Res Public Health       Date:  2005-04       Impact factor: 3.390

10.  Fan1 deficiency results in DNA interstrand cross-link repair defects, enhanced tissue karyomegaly, and organ dysfunction.

Authors:  Supawat Thongthip; Marina Bellani; Siobhan Q Gregg; Sunandini Sridhar; Brooke A Conti; Yanglu Chen; Michael M Seidman; Agata Smogorzewska
Journal:  Genes Dev       Date:  2016-03-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.